IRIS
BONIFACINO, TIZIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.691
AS - Asia 2.521
NA - Nord America 2.219
Continente sconosciuto - Info sul continente non disponibili 555
SA - Sud America 219
AF - Africa 42
OC - Oceania 7
Totale 20.254
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.277
US - Stati Uniti d'America 2.072
SG - Singapore 994
CN - Cina 673
VN - Vietnam 461
BD - Bangladesh 160
BR - Brasile 129
FR - Francia 128
FI - Finlandia 75
HK - Hong Kong 75
CA - Canada 57
GB - Regno Unito 45
AR - Argentina 44
MX - Messico 42
DE - Germania 35
JP - Giappone 28
ID - Indonesia 23
ES - Italia 18
IQ - Iraq 17
JM - Giamaica 16
CH - Svizzera 14
ZA - Sudafrica 14
IN - India 13
PL - Polonia 13
UA - Ucraina 13
CO - Colombia 11
RU - Federazione Russa 11
IE - Irlanda 10
NL - Olanda 10
SA - Arabia Saudita 10
CL - Cile 8
EC - Ecuador 8
PH - Filippine 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
DZ - Algeria 7
MY - Malesia 7
PK - Pakistan 7
TT - Trinidad e Tobago 7
VE - Venezuela 7
AU - Australia 6
PY - Paraguay 6
SI - Slovenia 6
SE - Svezia 5
HN - Honduras 4
LT - Lituania 4
RO - Romania 4
TR - Turchia 4
AT - Austria 3
BO - Bolivia 3
JO - Giordania 3
KR - Corea 3
NP - Nepal 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
BS - Bahamas 2
EG - Egitto 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
LY - Libia 2
MA - Marocco 2
MD - Moldavia 2
MT - Malta 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
TH - Thailandia 2
TN - Tunisia 2
AI - Anguilla 1
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
KW - Kuwait 1
NC - Nuova Caledonia 1
QA - Qatar 1
SC - Seychelles 1
SD - Sudan 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 19.699
Salva come PNG Salva come JPEG
Città #
Genova 6.178
Genoa 5.305
Vado Ligure 1.295
Rapallo 1.170
San Jose 554
Singapore 509
Ashburn 236
Ho Chi Minh City 150
Lauterbourg 111
Beijing 109
Hanoi 107
Council Bluffs 92
New York 87
Helsinki 74
Hong Kong 72
Los Angeles 45
Santa Clara 40
Bordighera 34
Milan 30
Rome 28
Atlanta 27
Frankfurt am Main 27
Orem 25
Buffalo 24
São Paulo 23
Tokyo 23
Chicago 21
Da Nang 21
Haiphong 20
Montreal 19
Phoenix 18
Mexico City 17
Turin 17
Basingstoke 14
Zurich 14
Houston 13
Dallas 12
Kyiv 12
Baghdad 11
Naples 11
St Louis 11
The Dalles 11
Tianjin 11
Dublin 10
Brooklyn 9
Can Tho 9
Miami 9
Osio Sopra 9
Piscataway 9
Boardman 8
Charlotte 8
Denver 8
Fort Myers 8
Hải Dương 8
Johannesburg 8
Kingston 8
Staten Island 8
Cleveland 7
Hamden 7
Messina 7
Philadelphia 7
Quảng Ngãi 7
Amsterdam 6
Biên Hòa 6
Buenos Aires 6
Denton 6
Detroit 6
Ljubljana 6
London 6
Madrid 6
North Bergen 6
Paris 6
Phủ Lý 6
Toronto 6
Warsaw 6
Winnipeg 6
Barcelona 5
Bari 5
Florence 5
Jeddah 5
Las Vegas 5
Lexington 5
Louisville 5
Memphis 5
Newark 5
Padua 5
Pasadena 5
Queens 5
Quito 5
San Francisco 5
Thái Bình 5
Virginia Beach 5
Birmingham 4
Bologna 4
Bắc Ninh 4
Bến Tre 4
Catania 4
Cincinnati 4
Collingswood 4
Columbus 4
Totale 16.978
Salva come PNG Salva come JPEG
Nome #
Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 244
Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 243
Acute stress increases depolarization-evoked glutamate release and presynaptic SNARE complex accumulation in prefrontal/frontal cortex. The dampening action of antidepressants. 240
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis. 239
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 235
Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease 211
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways 210
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosis at a Pre-Symptomatic Stage of the Disease. 210
Chronic mild stress induces anhedonic behavior and changes in glutamate release, BDNF trafficking and dendrite morphology only in stress vulnerable rats. The rapid restorative action of ketamine 205
Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS 200
Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis. 194
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 188
The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release 187
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis 185
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 180
Colocalization of neurotransmitter transporters on the plasma membrane of the same nerve terminal may reflect cotransmission. 180
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone 177
Enriched experience and recovery from amblyopia in adult rats: impact of motor, social and sensory components. 174
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 170
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. 170
Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice 170
Metabotropic glutamate receptor 5 as a potential target in ALS 167
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex 164
Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis 163
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 162
Excessive and precocious glutamate release in the spinal cord of a mouse model of amyotrophic lateral sclerosis 162
Amyotrophic lateral sclerosis and excitotoxicity: role of Group I metabotropic glutamate receptors 161
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes 160
Abnormal and precocious exocytotic glutamate release in a mouse model of amyotrophic lateral sclerosis 160
Differential expression of metabotropic glutamate and GABA receptors at neocortical glutamatergic and GABAergic axon terminals 158
Glutamate release from astrocytic gliosomes under physiological and pathological conditions 157
Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down Syndrome. 155
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosisat a Pre-Symptomatic Stage of the Disease. 155
Role of calpain-1 in the early phase of experimental ALS 149
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 148
Astrocyte contribution to the excessive glutamate release in the spinal cord of the SOD1G93A mouse model of amyotrophic lateral sclerosis 148
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 148
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 147
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 147
mGluR1 and mGluR5 knock-down improves survival, motor skills and disease progression in amyotrophic lateral sclerosis mouse model 147
Abnormal glutamate release induced by group I metabotropic glutamate receptors in experimental ALS. 147
Targeting Group I Metabotropic Glutamate Receptors in Amyotrophic Lateral Sclerosis 146
Acute stress and corticosterone increase the readily releasable pool of glutamatergic vesicles in rat synaptosomes of prefrontal/frontal cortex via mineralocorticoid and glucocorticoid receptors 146
In vitro Evidence of Abnormal Glutamate to Glutamine Conversion in Astrocytes harvested from a Mouse Model of Amyotrophic Lateral Sclerosis: a potential Experimental Application of N-13-ammonia 146
Group I metabotropic glutamate receptors tune excitotoxicity in amyotrophic lateral sclerosis 143
Genetic and pharmacological effects of mGlu5 receptor blockade in the SOD1G93A mouse model of amyotrophic lateral sclerosis 143
Acute ketamine restores deficits in glutamate release and related molecular mechanisms induced by chronic mild stress in vulnerable rats 142
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice 141
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone. 140
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 140
A multistationary loop model of ALS unveils critical molecular interactions involving mitochondria and glucose metabolism 139
GroupI metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 136
GROUP I METABOTROPIC GLUTAMATE RECEPTORS AND NEUROTOXICITY IN AMYOTROPHIC LATERAL SCLEROSIS 136
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice 136
Altered synaptic mechanisms and excessive glutamate release in amyotrophic lateral sclerosis 135
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice 135
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 134
Synaptic mechanisms underlying the excessive and precocious glutamate release in the spinal cord of sod1g93a mice. 133
Knocking-down mGluR1 and mGluR5 in the SOD1/G93A mouse model of amyotrophic lateral sclerosis ameliorates survival and disease progression 133
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 133
Group I metabotropic glutamate receptors in ALS: knocking-down mGlu1 receptors ameliorates survival and disease progression in SOD1/G93A mice. 131
Genetic inactivation of metabotropic glutamate 5 (mGlu5) receptor ameliorates motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 131
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice 131
Molecular mechanisms supporting abnormal glutamate release in the spinal cord of a mouse model of Amyotrophic Lateral Sclerosis. 130
Targeting group i metabotropic glutamate receptors in experimental als. 130
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis 129
Group I metabotropic glutamate receptors modulate glutamate exocytosis in a mouse model of als 128
The Modulation of Glutamate Release by Group I Metabotropic Glutamate Auto-Receptors in ALS 127
Knocking-down mGlu1 receptors prolongs survival and ameliorates disease progression in the SOD1/G93A mouse model of ALS. 127
Genetic and pharmacological effects by blocking mGlu5 Receptor in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 127
Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex 127
In-vivo and in-vitro evidence supporting the role of mGlu5 receptor as a key regulator of glutamate downstream effects in ALS 127
Preclinical study showing a gender specific protective properties of conjugated linoleic acid (CLA) for amyotrophic lateral sclerosis 126
Increased [3H]D-aspartate release and changes in glutamate receptor expression in the hippocampus of the mnd mouse. 126
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS 126
Group I metabotropic glutamate receptors induce excessive glutamate release in the spinal cord of sod1g93a mice 125
Non conventional activity of the endocannabinoid system at glutamate release in rat cortical astrocytes 124
In-vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOd1/G93A(+) mouse model of amyotrophioc lateral sclerosis. 124
Ketamine modulates glutamate release, BDNF trafficking and dendrite morphology in rats vulnerable to chronic mild stress 124
Knocking-down mGluR1 and mGluR5 in SOD1G93A mice ameliorates survival and disease progression 124
Sex Differences in CASA-Mediated Autophagy in ALS Glial Cells 123
GLUTAMATE NEUROTRANSMISSION IS MODIFIED IN THE SOD1/G93A MOUSE MODEL OF ALS 123
The modulation of Glutamate release by Group I metabotropic Glutamate auto-receptors in ALS 123
Knocking down mglu1 receptors prolongs survival and improves symptomatology in a mouse model of amyotrophic lateral sclerosis 120
Inactivation of the Grm5 gene improves motor coordination defects in the Grm1crv4 mouse model of SCAR13 ataxia 120
Acute stress increases the readily releasable pool of glutamate vesicles in cortical areas 119
Synaptic Mechanisms Sustaining The Excessive And Precocious Glutamate Release In The Spinal Cord Of SOD1G93A Mice 119
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 118
Fluoxetine treatment promotes functional recovery in a rat model of cervical spinal cord injury 118
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through corticosterone non-genomic action 118
Altered expression of the GPR17 receptor in the spinal cord of SOD1G93A mice, a model of amyotrophic lateral sclerosis 118
Mesemchymal stem cells systemically administered in symptomatic mutant SOD1-G93A mice ameliorate survival and motor abilities 117
Group I metabotropic glutamate receptors in ALS: mGluR1 and mGluR5 autoreceptors induce excessive glutamate release in SOD1/G93A mice. 116
Knocking-down Group I metabotropic glutamate receptors ameliorates survival and disease progression in SOD1G93A mice. 116
Reducing the expression of mGlu1 and mGlu5 receptors ameliorates survival and disease progression in SOD1G93A mice 116
Excessive glutamate release and undelying synaptic mechanisms in a mouse model of amyotrophic lateral sclerosis 115
null 114
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases 113
mGlu5 receptor negative allosteric modulation reduces the aberrant cellular reactivity and neurotoxicity of reactive human astrocytes differentiated from fibroblast of SOD1 and C9orf72 ALS patients 113
Phenotype changes of microglia in SOD1G93A mice after mGluR5 genetic down regulation 112
Totale 14.849
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.859
article - articoli 27.210
book - libri 550
conference - conferenze 36.099
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.718
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.332 21 85 62 127 50 107 83 322 84 126 68 197
2022/20231.440 137 147 21 164 212 201 15 104 214 12 183 30
2023/20241.113 36 124 33 135 80 235 95 43 46 61 74 151
2024/20253.571 189 237 82 240 388 325 302 664 103 159 408 474
2025/20266.869 822 173 435 497 1.070 433 959 382 569 728 362 439
2026/2027644 644 0 0 0 0 0 0 0 0 0 0 0
Totale 20.254